LCA168 FOR GLIOBLASTOMA?

Glioblastoma is a formidable brain cancer known for its fast growth and resistance to conventional treatments. Investigations are constantly underway to identify new management strategies, and recently, a new biomarker named LCA168 has emerged as a potential target for glioblastoma treatment. LCA168 is a protein that is highly expressed in GBM cel